TI
OCRX

Turner Investments’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Turner Investments’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-134,419
Closed -$355K – 309
2016
Q3 		$355K Sell
134,419
-5,297
-4% -$13.2K 0.12% 156
2016
Q2 		$265K Sell
139,716
-310,284
-69% -$816K 0.08% 171
2016
Q1 		$1.32M Sell
450,000
-223,487
-33% -$638K 0.36% 96
2015
Q4 		$2.1M Buy
673,487
+152,210
+29% +$520K 0.43% 73
2015
Q3 		$1.65M Buy
521,277
+421,199
+421% +$1.62M 0.33% 99
2015
Q2 		$380K Buy
100,078
+33,138
+50% +$127K 0.07% 226
2015
Q1 		$315K Buy
66,940
+4,930
+8% +$28.4K 0.06% 271
2014
Q4 		$395K Sell
62,010
-146,540
-70% -$857K 0.05% 364
2014
Q3 		$1.02M Buy
208,550
+190,730
+1,070% +$1.1M 0.06% 346
2014
Q2 		$136K Buy
+17,820
New +$142K 0.01% 510

Other funds holding OCRX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Turner Investments's OCRX Position: Q4 2016 in Review

Turner Investments sold out of Ocera Therapeutics, Inc. (OCRX) in Q4 2016, closing a stake of 134,419 shares — an estimated $355K sold.

Turner Investments first reported a position in OCRX in Q2 2014 and held it in 10 quarters. The position peaked at $2.1M in Q4 2015. 36 funds tracked by Wall St. Rank hold OCRX as of Q4 2016.

  • Turner Investments reported no remaining Ocera Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Turner Investments sold 134,419 Ocera Therapeutics, Inc. shares in Q4 2016, an estimated $355K.
  • Turner Investments first reported a position in Ocera Therapeutics, Inc. in Q2 2014 and held it in 10 quarters.
  • Turner Investments's Ocera Therapeutics, Inc. position peaked at $2.1M in Q4 2015.
  • 36 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q4 2016.

Based on Turner Investments's 13F filing for Q4 2016, filed 8 Feb 2017.